Veeva Systems introduces AI to boost life sciences productivity

Published 29/04/2025, 12:10
Veeva Systems introduces AI to boost life sciences productivity

PLEASANTON, Calif. - Veeva Systems (NYSE:VEEV), a highly profitable cloud software provider with a 74.5% gross margin and $2.7 billion in annual revenue, today unveiled Veeva AI, an initiative designed to integrate artificial intelligence into the Veeva Vault Platform and its suite of applications. According to InvestingPro data, the company maintains excellent financial health with a "GREAT" overall score, supported by strong growth metrics and robust cash flows. This development aims to enhance automation and increase productivity for life sciences companies by introducing AI Agents and AI Shortcuts across various functions, from clinical operations to commercial activities.

Veeva AI Agents are tailored to interact with the company’s applications, offering application-specific prompts and safeguards while accessing data, documents, and workflows securely. These agents can be customized or extended by customers to meet unique business needs and can be operated through a chat interface or an AI API.

Additionally, Veeva AI Shortcuts allow users to create personal AI-driven automations for routine tasks, potentially streamlining workflows and generating insights. Veeva CEO Peter Gassner highlighted the potential of this "GenAI" computing paradigm to significantly enhance knowledge worker productivity by combining core applications’ structured data and workflow capabilities with AI’s more human-like problem-solving skills.

The platform’s agnostic approach to large language models (LLMs) enables customers to choose either a Veeva-supplied LLM or their own, ensuring data security regardless of the LLM employed. This flexibility aligns with Veeva’s strong market position, reflected in its 16.2% revenue growth and impressive 4.5x current ratio, indicating excellent operational efficiency and financial stability.

Veeva Systems, a global leader in cloud software for the life sciences industry, plans to release the first iteration of Veeva AI in December 2025. The service will be available on a subscription basis, with the intention of promoting widespread and thoughtful industry adoption.

This announcement is based on a press release statement and contains forward-looking statements about the product’s development and anticipated benefits. These expectations are subject to risks and uncertainties that could affect the actual results, availability, and future product-related events, as disclosed in Veeva’s filings with the SEC.

The introduction of Veeva AI reflects the company’s commitment to customer success and innovation, aligning with its status as a Public Benefit Corporation that considers the interests of various stakeholders in the life sciences sector. Trading at a P/E ratio of 51.1, Veeva’s premium valuation reflects market confidence in its growth potential. For deeper insights into Veeva’s valuation and growth prospects, including 8 additional exclusive ProTips, check out the comprehensive research report available on InvestingPro.

In other recent news, Veeva Systems reported a strong fourth-quarter performance, surpassing expectations with notable growth in normalized billings and subscription margins. The company added 20 new Vault CRM customers and 41 new Quality customers, showcasing robust product adoption. Analysts from Citi and Stifel have maintained their Buy ratings, with price targets set at $307 and $272, respectively, citing Veeva’s promising FY26 guidance, which includes a projected 11% revenue growth and an 11% increase in billings. The guidance also suggests a 14% growth in subscription services, which constitute a significant portion of Veeva’s revenue. Meanwhile, Raymond James reiterated an Outperform rating with a $285 target, noting stable revenue contributions from Veeva’s top customers and a 17% growth in billings in the fourth fiscal quarter. Additionally, TD Cowen raised its price target for Veeva to $261, acknowledging the company’s strong R&D growth and improved operating income margins for FY26. In governance-related news, Veeva Systems announced the retirement of board member Tina Hunt, effective before the 2025 annual meeting of shareholders. The company has not disclosed plans for her replacement, leaving investors attentive to any forthcoming announcements regarding the board’s composition.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.